Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in
Maura Pugliatti(University of Sassari), Thomas Berger(Medical University of Vienna), Patrick Vermersch(Université de Lille), Andrew Chan(Infosys (India)), Laura Airas(Turku University Hospital), Hans‐Peter Hartung(The University of Sydney), Mona Alkhawajah(Alfaisal University), Nikolaos Grigoriadis(Aristotle University of Thessaloniki), Carlo Pozzilli(Ophthalmology Clinic), Celia Oreja‐Guevara, Ralf A. Linker(St. Josef-Hospital), Melinda Magyari(University of Copenhagen), Bart Van Wijmeersch(Hasselt University), Magd Zakaria(Ain Shams University)
Cited by 11
Related Papers
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k